Effect of Sex on Reverse Remodeling in Chronic Systolic Heart Failure

被引:32
|
作者
Aimo, Alberto [1 ]
Vergaro, Giuseppe [1 ,2 ]
Castiglione, Vincenzo [1 ]
Barison, Andrea [1 ,2 ]
Pasanisi, Emilio [2 ]
Petersen, Christina [2 ]
Chubuchny, Vladyslav [2 ]
Giannoni, Alberto [2 ]
Poletti, Roberta [2 ]
Maffei, Silvia [2 ]
Januzzi, James L., Jr. [3 ,4 ]
Passino, Claudio [1 ,2 ]
Emdin, Michele [1 ,2 ]
机构
[1] Scuola Super Sant Anna, Inst Life Sci, Pisa, Italy
[2] Fdn Toscana Gabriele Monasterio, Div Cardiol, Pisa, Italy
[3] Massachusetts Gen Hosp, Div Cardiol, Boston, MA 02114 USA
[4] Harvard Clin Res Inst, Boston, MA USA
关键词
heart failure; reverse remodeling; sex; ESTROGEN-RECEPTOR-ALPHA; CARDIAC RESYNCHRONIZATION THERAPY; ECHOCARDIOGRAPHIC-ASSESSMENT; CLINICAL CHARACTERISTICS; DILATED CARDIOMYOPATHY; EUROPEAN ASSOCIATION; HORMONES; GENDER; HYPERTROPHY; PREVALENCE;
D O I
10.1016/j.jchf.2017.07.011
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This study sought to investigate sex-related differences in reverse remodeling (RR). BACKGROUND RR, that is, the recovery from left ventricular (LV) dilation and dysfunction in response to treatment for heart failure (HF), is associated with improved prognosis. METHODS Data from patients with stable systolic HF (LV ejection fraction [LVEF] of <50%) undergoing 2 transthoracic echocardiograms within 12 +/- 2 months were analyzed. Reverse remodeling was defined as a >= 15% reduction in LV end-systolic volume index. RESULTS A total of 927 patients were evaluated (68 +/- 12 years; median LVEF = 35% [interquartile range: 30% to 43%]; 27% women). Ischemic HF was less often encountered in women (33% vs. 60%, respectively; p < 0.001), whereas most characteristics did not differ with regard to sex. Women showed a higher incidence of RR (41% vs. 27%, respectively; p < 0.001), despite similar baseline LV volume and function. RR was more frequent among women in the subgroups with either ischemic or nonischemic HF, as well as in all categories of systolic dysfunction (LVEF <= 35% or >35%, according to current indication for device implantation, and LVEF <40% or 40% to 50% according to the definition of HF with reduced or mid-range EF). In the whole population, female sex was an independent predictor of RR (hazard ratio: 1.54; 95% confidence interval: 1.11 to 2.14; p = 0.011), together with cause of HF, disease duration, and left bundle branch block. Female sex was again an independent predictor of RR in all LVEF categories. CONCLUSIONS Reverse remodeling is more frequent among women, regardless of cause and severity of LV dysfunction. Female sex is an independent predictor of RR in all categories of LV systolic dysfunction. (C) 2017 by the American College of Cardiology Foundation.
引用
收藏
页码:735 / 742
页数:8
相关论文
共 50 条
  • [21] Metabolic remodeling in chronic heart failure
    Wang, Jing
    Guo, Tao
    JOURNAL OF ZHEJIANG UNIVERSITY-SCIENCE B, 2013, 14 (08): : 688 - 695
  • [22] Neuregulin as a heart failure therapy and mediator of reverse remodeling
    Galindo C.L.
    Ryzhov S.
    Sawyer D.B.
    Current Heart Failure Reports, 2014, 11 (1) : 40 - 49
  • [23] Reverse remodeling in heart failure—mechanisms and therapeutic opportunities
    Norimichi Koitabashi
    David A. Kass
    Nature Reviews Cardiology, 2012, 9 : 147 - 157
  • [24] Remodeling Chromatin Structure To Induce And Reverse Heart Failure
    Rosa-Garrido, Manuel
    Bridges, Justin
    Chapski, Douglas
    CIRCULATION RESEARCH, 2023, 133
  • [25] Reverse remodeling in heart failure with intensification of vasodilator therapy
    Levine, TB
    Levine, AB
    Keteyian, SJ
    Narins, B
    Lesch, M
    CLINICAL CARDIOLOGY, 1997, 20 (08) : 697 - 702
  • [26] CRT In Mild Heart Failure: Left Ventricular Remodeling In Relation To Heart Failure Etiology. Results From The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunctie (reverse) Study
    Ghio, Stefano
    Sutton, Martin St. John
    Tavazzi, Luigi
    Plappert, Ted
    Daubert, Jean Claude
    Abraham, William T.
    Gold, Michael R.
    Linde, Cecilia
    CIRCULATION, 2008, 118 (18) : S869 - S869
  • [27] Drug Treatment for Chronic Systolic Heart Failure
    Moerike, K.
    Sindermann, J. R.
    THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 : S170 - S172
  • [28] Office Management of Chronic Systolic Heart Failure
    Geraci, Stephen A.
    Spencer, Jessie M.
    Stubbs, Nancy D.
    AMERICAN JOURNAL OF MEDICINE, 2009, 122 (04): : 329 - 332
  • [29] Immunosenescence in patients with chronic systolic heart failure
    Xydonas, Sotirios
    Parissis, John
    Lioni, Louiza
    Kapsimali, Violetta
    Psarra, Ekaterini
    Farmakis, Dimitrios
    Kremastinos, Dimitrios
    Lekakis, John
    Sideris, Antonios
    Tsirogianni, Alexandra
    Filippatos, Gerasimos
    JOURNAL OF CARDIOVASCULAR MEDICINE, 2016, 17 (08) : 624 - 630
  • [30] Establishment and Comparison of Myocardial Remodeling in Rabbit Models with Diastolic Heart Failure and Systolic Heart Failure
    Wang, Lei
    Wang, Hai-Peng
    Zhao, Cai-Ming
    Han, Lian-Hua
    Zou, Cao
    Liu, Zhi-Hua
    Jiang, Wen-Ping
    CIRCULATION, 2010, 122 (02) : E132 - E133